Jim Shannon – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Jim Shannon on 2016-10-18.

To ask the Secretary of State for Health, what discussions NHS England has had with clinical bodies on the introduction of new treatments based on immunotherapy.

David Mowat

NHS England already funds some immunotherapy treatments for kidney cancer, lung cancer, and melanoma.

It has had detailed discussions around the potential use of immunotherapies with the National Institute for Health and Care Excellence; the NHS England Chemotherapy Clinical Reference Group; and the Cancer Drug Fund team. They regularly draw on expertise from specific clinical professional groups and patient organisations when considering treatment decisions.